YTYingying Tan

Yingying Tan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yingying Tan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efficacy of traditional Chinese medicine decoctions combined with conventional therapy for pediatric asthma: a network meta-analysis

    by Yan Zhao, Meina Li, Ai Ai, Xin He, Xingyu Liu, Weiwei Tian, Yingying Tan

    Objective: This study aimed to explore the potential comparative effectiveness of various traditional Chinese medicine (TCM) decoctions plus conventional biomedical treatment (CBT) versus CBT alone in pediatric asthma using a Bayesian network meta-analysis (NMA). Methods: Seven databases were systematically searched for randomized controlled trials (RCTs) published up to 24 March 2025 that evaluated TCM decoctions in the treatment of pediatric asthma. The Bayesian NMA was conducted using R 4.4.1 and Stata 15.1. Risk of bias was assessed using the Cochrane tool (Review Manager 5.4.1), and interventions were tentatively ranked by surface under the cumulative ranking curve (SUCRA). Results: A total of 21 RCTs involving 2,068 patients and 9 distinct TCM decoctions were included. The risk of bias was high or unclear in all studies included, with particular concerns regarding allocation concealment and blinding. Compared with CBT alone, Qing Qi Hua Tan Tang (QQHTT) + CBT significantly improved forced expiratory volume in one second (FEV1) (mean difference [MD] 1.20; 95% credible interval [CrI] [1.10, 1.40]). Ma Xing Shi Gan Tang (MXSGT) + CBT significantly increased peak expiratory flow (PEF) (MD 12.00; 95% CrI [8.00, 17.00]). According to SUCRA, QQHTT + CBT (SUCRA = 99.9%) and MXSGT + CBT (SUCRA = 97.1%) ranked highest for FEV1 and PEF. Conclusion: Sensitivity analyses confirmed the stability of the results regarding FVC and IgG, with Ma Xing Shi Gan Tang He Su Ting Wan (MXSGTHSTW) + CBT and Xiao Qing Long Tang (XQLT) + CBT which was ranked first in all analyses. For FEV1, the top-ranked interventions (QQHTT, Da Qing Long Tang [DQLT], MXSGTHSTW) remained in the top three across all analyses, with minor changes in ranking attributable to differences in inclusion criteria across studies. For PEF, the rankings in sensitivity analysis 1 were influenced by a reduction in the number of eligible treatments. For IgE, no decoction showed statistically significant differences, and the rankings were sensitive to the conditions of the analysis. Although QQHTT and MXSGT demonstrated statistical advantages in this NMA, serious methodological limitations exist in the included studies, particularly the lack of blinding and allocation concealment. Moreover, the inability to fully ensure the comparability of TCM decoctions means that these findings should be regarded as preliminary, hypothesis-generating and exploratory. Systematic Review Registration: identifier CRD420251120217.

  • Open Access

    Mass Yields, Antioxidant and Anti-DU145 Prostate Cancer Cell Proliferation Properties of ProSoy Soymilk as Affected by Extraction Methods and Cooking

    by Sam K. C. Chang, Yingying Tan

    Both the soybean variety and processing method affect the end soybean product’s characteristics. This study’s objective was to characterize the effects of four extraction methods (variations of soaking and grinding) combined with cooking on the content and composition of phenolic substances and the antioxidant and anti-DU145 prostate cancer cell proliferation properties of soymilks prepared from a yellow soybean of the ProSoy variety, which is a high-protein variety. The results showed that the soymilk processing yield was the greatest using method 4, although method 2 gave the highest solid and protein yields by about 14 and 12%, respectively. Method 4, a two-step grinding method, also gave increased yields (8 and 7% for solids and proteins, respectively), and in all but one instance produced higher total phenolic content (TPC), total flavonoid content (TFC), condensed tannin content (CTC), and total isoflavone content values in both raw and cooked soymilks as compared to method 1. Cooking the soymilks reduced 14–17% of their total phenolic substances. Cooking reduced the anti-cancer capacity of the phenolic extracts from the soymilk prepared using method 4 by increasing the IC50 value from about 4.9 mg/mL to 6.8 mg/mL. The increases in phenolic compounds and antioxidants produced in the Prosoy soymilks using methods 2 and 4, with simultaneous increases in product and solid yields, are of significant benefit to the soymilk industry and consumer health.


  • Open Access

    Mass Yield, Antioxidant and Anti-Prostate Cancer DU145 Cell Proliferative Properties of ProSoy Soymilk as Affected by Extraction Methods and Cooking

    by Sam K.C. Chang, Yingying Tan

    Both soybean variety and processing affect product characteristics. This study’s objective was to characterize the effect of four extraction methods (variations of soaking and grinding) combined with cooking on the content and composition of phenolic substances, antioxidant and anti-DU145 prostate cancer cell proliferative properties of soymilk prepared from a yellow soybean of the ProSoy variety, which is a high protein variety. Results showed soymilk processing yield was the greatest by Method 4, but Method 2 gave the highest solids and protein yields by about 14 and 12%, respectively. Method 4, a two-step grinding also increased yields (8 and 7%, for solids and protein, respectively), and in all but one instance produced higher total phenolic content (TPC), total flavonoid content (TFC), condensed tannin content (CTC) and total isoflavone content in both raw and cooked soymilk as compared to Method 1. Cooking soymilk reduced 14-17% of total phenolic substances. Cooking reduced anticancer capacity of Method-4-prepared soymilk phenolic extract by increasing IC50 value from about 4.9 mg/mL to 6.8 mg/mL. The increases in phenolic compounds and antioxidants produced in Prosoy soymilk by Methods 2 and 4 with simultaneous increases in product solids yield are significant to benefit the soymilk industry and consumer health. Keywords: ProSoy yellow soybean, soymilk processing, phenolics, isoflavones, antioxidant capacity, anti-DU145 prostate cancer proliferation


  • Open Access

    Da-Chuan-Xiong Decoction Ameliorates Sodium Sensitivity and Plasma Norepinephrine via Attenuation of Brain Oxidative Stress in the DOCA-Salt Hypertensive Rats

    by Qi Zhang, Hao Li, Shan Zhao, Fangfang Li, Yingying Tan

    Background. Da-Chuan-Xiong Decoction (DCXD) is an aqueous extract from a classic Chinese herbal formula composed of dried rhizomes of Ligusticum chuanxiong Hort and Gastrodia elata Bl. in the mass ratio of 4:1. It has been long used to treat chronic cardiovascular disease caused by blood stasis and wind pathogen in the clinic. This experimental study aimed to investigate the blood pressure (BP)-lowering effect of DCXD treatment on hypertension and underlying mechanisms. Methods. Male SpragueDawley rats were used in the experiment, and the hypertensive models were created by administering deoxycorticosterone acetate (DOCA) in conjunction with a high salt intake in uninephrectomized rats. DCXD was administered to hypertensive rats by oral gavage daily at a dose of 5g/kg or 2.5g/kg bodyweight for 28days. The brain sodium sensitivity, ENaC function, superoxide anion level, NADPH oxidase activity, and expression of ENaC, p67phox, p47phox, and Rac1 in the paraventricular nucleus were assessed by using the appropriate methods. Results. The 28days of DCXD (5g/kg) treatment significantly reduced the increased BP effectively, inhibited the enhanced heart index, kidney index, and 24h urinary protein, and improved the progressive pathological changes of heart and kidney, which was comparable to that of the positive control amlodipine. DCXD treatment also caused a marked reduction in plasma norepinephrine and induced a significant improvement in brain sodium sensitivity and ENaC function in DOCA-salt hypertensive rats. Rats in DCXD-treated groups also exhibited decreased superoxide anion levels and NADPH oxidase activity in the paraventricular nucleus. The level of ENaC, p67phox, and Rac1 protein expression in the paraventricular nucleus was significantly downregulated by DCXD treatment in DOCA-salt hypertensive rats. Conclusions. These findings indicate that the depressor action and sympathetic inhibition of DCXD on salt-sensitive hypertension may be by ameliorating brain sodium sensitivity, modulating ENaC function, and inhibiting the expression of ENaC and NADPH oxidase in the hypothalamic paraventricular nucleus.


  • Open Access

    Involvement of Neuropeptide Y within Paraventricular Nucleus in Electroacupuncture Inhibiting Sympathetic Activities in Hypertensive Rats

    by Qi Zhang, Yingying Tan, Xin Wen, Fangfang Li

    Although electroacupuncture (EA) has been used to decrease the blood pressure (BP) clinically, the underlying mechanisms are not clearly clarified. This study aimed to assess the hypothesis that EA treatment exerts a hypotensive action via suppressing sympathetic activities and modulating neuropeptide Y (NPY) function within the paraventricular nucleus (PVN) of hypertensive rats. Male Sprague-Dawley rats were selected for the experiment, and the hypertensive models were established by the two-kidney, one-clip (2K1C) method. Then, the rats were randomly assigned to the sham group, 2K1C group, 2K1C plus EA group, and 2K1C plus sham EA group. EA treatment at the acupoints ST36 and ST40 overlying the peroneal nerves was given once a day for 30 days. The radiotelemetry system was applied to collect the arterial BP recordings. Power spectral analyses of BP variability, BP responses to ganglionic blockade, and plasma levels of norepinephrine and epinephrine were performed to assess the changes in sympathetic nerve activity. Real-time PCR and Western blots were carried out to examine the expression of NPY system in the PVN. The responses of PVN microinjection with NPY Y1R antagonist BIBO3304 were detected to check the endogenous NPY tone. The results showed that the enhanced arterial BP and sympathetic activities were effectively reduced by 30 days of EA treatment, and baroreflex sensitivity was improved in 2K1C hypertensive rats. The level of NPY mRNA and protein expression in the PVN was markedly upregulated by EA treatment in 2K1C rats. In addition, the pressor responses of PVN microinjection with NPY Y1R antagonist BIBO3304 in 2K1C models were remarkably augmented by the EA stimulation. Our results indicate that the increased NPY expression and function in the PVN induced by EA treatment contribute to antihypertensive and sympathetic suppression on hypertensive rats. The findings may elucidate the underlying mechanisms of the acupuncture to be a potential therapeutic strategy against hypertension.